{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T05:31:05Z","timestamp":1769059865795,"version":"3.49.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,4,5]],"date-time":"2019-04-05T00:00:00Z","timestamp":1554422400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12879-019-3944-0","type":"journal-article","created":{"date-parts":[[2019,4,5]],"date-time":"2019-04-05T13:03:08Z","timestamp":1554469388000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Safety and efficacy of prophylaxis for Pneumocystis jirovecii pneumonia involving trimethoprim-sulfamethoxazole dose reduction in kidney transplantation"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1576-7696","authenticated-orcid":false,"given":"G. V. Ramesh","family":"Prasad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jill","family":"Beckley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohit","family":"Mathur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madhushankar","family":"Gunasekaran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle M.","family":"Nash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lindita","family":"Rapi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey S.","family":"Zaltzman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,4,5]]},"reference":[{"key":"3944_CR1","doi-asserted-by":"crossref","unstructured":"Martin SI, Fishman JA and The AST infectious diseases Community of Practice. Pneumocystis pneumonia in solid organ transplantation. Am J Transplant 2013; 13: 272\u2013279.","DOI":"10.1111\/ajt.12119"},{"key":"3944_CR2","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1111\/ajt.12947","volume":"15","author":"X Iriart","year":"2015","unstructured":"Iriart X, Challan Belval T, Fillaux J, Esposito L, Lavergne RA, Cardeau-Desangles I, et al. Risk factors of Pneumocystis pneumonia in solid organ recipients in the era of the common use of posttransplantation prophylaxis. Am J Transplant. 2015;15:190\u20139.","journal-title":"Am J Transplant"},{"key":"3944_CR3","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1111\/j.1399-3062.2011.00691.x","volume":"13","author":"N Goto","year":"2011","unstructured":"Goto N, Oka S. Pneumocystis jirovecii pneumonia in kidney transplantation. Transpl Infect Dis. 2011;13:551\u20138.","journal-title":"Transpl Infect Dis"},{"key":"3944_CR4","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1093\/jac\/dkw157","volume":"71","author":"J Maertens","year":"2016","unstructured":"Maertens J, Cesaro S, Maschmeyer G, Einsele H, Donnelly JP, Alanio A, et al. ECIL guidelines for preventing Pneumocystis jiroveci pneumonia in patients with haematological malignancies and stem cell transplant recipients. J Antimicrob Chemother. 2016;71:2397\u2013404.","journal-title":"J Antimicrob Chemother"},{"key":"3944_CR5","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1128\/CMR.17.4.770-782.2004","volume":"17","author":"M Rodriguez","year":"2004","unstructured":"Rodriguez M, Fishman JA. Prevention of infection due to Pneumocystis spp. in human immunodeficiency virus-negative immunocompromised patients. Clin Microbiol Rev. 2004;17:770\u201382.","journal-title":"Clin Microbiol Rev"},{"key":"3944_CR6","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.1001\/jama.2009.880","volume":"301","author":"JA Kovacs","year":"2009","unstructured":"Kovacs JA, Masur H. Evolving health effects of Pneumocystis. One hundred years of progress in diagnosis and treatment. JAMA. 2009;301:2578\u201385.","journal-title":"JAMA"},{"key":"3944_CR7","doi-asserted-by":"publisher","first-page":"663","DOI":"10.7326\/0003-4819-100-5-663","volume":"100","author":"JA Kovacs","year":"1984","unstructured":"Kovacs JA, Hiemenz JW, Macher AM, et al. Pneumocystis carinii pneumonia: a comparison between patients with the acquired immunodeficiency syndrome and patients with other immunodeficiencies. Ann Intern Med. 1984;100:663\u201371.","journal-title":"Ann Intern Med"},{"key":"3944_CR8","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1503\/cmaj.111152","volume":"183","author":"JM Ho","year":"2011","unstructured":"Ho JM, Juurlink DN. Considerations when prescribing trimethoprim-sulfamethoxazole. CMAJ. 2011;183:1851\u20138.","journal-title":"CMAJ"},{"key":"3944_CR9","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.4065\/82.9.1052","volume":"82","author":"H Green","year":"2007","unstructured":"Green H, Paul M, Vidal L, Leibovici L. Prophylaxis of Pnumocystis pneumonia in immunocompromised non-HIV infected patients: systematic review and meta-analysis of randomized controlled trials. Mayo Clin Proc. 2007;82:1052\u20139.","journal-title":"Mayo Clin Proc"},{"key":"3944_CR10","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1086\/520433","volume":"29","author":"WM El-Sadr","year":"1999","unstructured":"El-Sadr WM, Luskin-Hawk R, Yurik TM, et al. Terry Beirn community programs for clinical research on AIDS (CPCRA). A randomized trial of daily and thrice-weekly trimethoprim-sulfamethoxazole for the prevention of Pneumocuystis cariniii pneumonia in human immunodeficiency virus-infected persons. Clin Infect Dis. 1999;29:775\u201383.","journal-title":"Clin Infect Dis"},{"key":"3944_CR11","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1086\/520434","volume":"29","author":"P Gaut","year":"1999","unstructured":"Gaut P, Daar ES. Editorial response: prophylaxis for Pneumocystis carinii pneumonia--an evolving tale of two populations. Clin Infect Dis. 1999;29:784\u20136.","journal-title":"Clin Infect Dis"},{"key":"3944_CR12","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1016\/j.transproceed.2009.03.004","volume":"41","author":"P Cocco Di","year":"2009","unstructured":"Di Cocco P, Orlando G, Bonanni L, D\u2019Angelo M, Clemente K, Greco S, Gravante G, Madeddu F, Scelzo C, Famulari A, Pisani F. A systematic review of two different trimethoprim-sulfamethoxazole regimens used to prevent Pneumocystis jiroveci and no prophylaxis at all in transplant recipeints: appraising the evidence. Transplant Proc. 2009;41:1201\u20133.","journal-title":"Transplant Proc"},{"key":"3944_CR13","doi-asserted-by":"publisher","first-page":"296","DOI":"10.7326\/0003-4819-119-4-199308150-00008","volume":"119","author":"H Velazquez","year":"1993","unstructured":"Velazquez H, Perazella MA, Wright FS, Ellison DH. Renal mechanism of trimethoprim-induced hyperkalemia. Ann Intern Med. 1993;119:296\u2013301.","journal-title":"Ann Intern Med"},{"key":"3944_CR14","doi-asserted-by":"publisher","first-page":"291","DOI":"10.7326\/0003-4819-119-4-199308150-00007","volume":"119","author":"S Greenberg","year":"1993","unstructured":"Greenberg S, Reiser IW, Chou SY, Porush JG. Trimethoprim-sulfamethoxazole induces reversible hyperkalemia. Ann Intern Med. 1993;119:291\u20135.","journal-title":"Ann Intern Med"},{"key":"3944_CR15","doi-asserted-by":"publisher","first-page":"467","DOI":"10.2169\/internalmedicine.55.5697","volume":"55","author":"K Higashioka","year":"2016","unstructured":"Higashioka K, Niiro H, Yoshida K, Oryoji K, Kamada K, Mizuki S, Yokota E. Renal insufficiency in concert with renin-agiotensin-aldosterone inhibition is a major risk factor for hyperkalemia associated with low-dose trimethoprim-sulfamethoxazole in adults. Intern Med. 2016;55:467\u201371.","journal-title":"Intern Med"},{"key":"3944_CR16","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.2215\/CJN.01970310","volume":"5","author":"MA Weir","year":"2010","unstructured":"Weir MA, Juurlink DN, Gomes T, Mamdani M, Hackam DG, Jain AK, Garg AX. Beta-blockers, trimethoprim-sulfamethoxazole, and the risk of hyperkalemia requiring hospitalization in the elderly: a nested case-control study. Clin J Am Soc Nephrol. 2010;5:1544\u201351.","journal-title":"Clin J Am Soc Nephrol"},{"key":"3944_CR17","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1007\/s40264-014-0196-1","volume":"37","author":"C Ben Salem","year":"2014","unstructured":"Ben Salem C, Badreddine A, Fathallah N, Slim R, Hmouda H. Drug-induced hyperkalemia. Drug Saf. 2014;37:677\u201392.","journal-title":"Drug Saf"},{"key":"3944_CR18","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1200\/JCO.1995.13.1.239","volume":"13","author":"MA Lew","year":"1995","unstructured":"Lew MA, Kehoe K, Ritz J, Antman KH, Nadler L, Kalish LA, Finberg R. Ciprofloxacin versus trimethoprim\/sulfamethoxazole for prophylaxis of bacterial infections in bone marrow transplant recipients: a randomized, controlled trial. J Clin Oncol. 1995;13:239\u201350.","journal-title":"J Clin Oncol"},{"issue":"Suppl 5","key":"3944_CR19","doi-asserted-by":"publisher","first-page":"S248","DOI":"10.1007\/BF01643198","volume":"15","author":"H Heimpel","year":"1987","unstructured":"Heimpel H, Raghavachar A. Hematological side effects of co-trimoxazole. Infection. 1987;15(Suppl 5):S248\u201353.","journal-title":"Infection"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-3944-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-019-3944-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-3944-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T23:05:34Z","timestamp":1585955134000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-019-3944-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,5]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["3944"],"URL":"https:\/\/doi.org\/10.1186\/s12879-019-3944-0","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,5]]},"assertion":[{"value":"11 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Research Ethics Board at St. Michael\u2019s Hospital, Toronto, protocol number REB 16\u2013210. Consent to participate was not required due to the population-based nature of the study, as approved by the Research Ethics Board at St. Michael\u2019s Hospital, Toronto. Administrative permission to access the raw data was provided by the Kidney Transplant Program, St. Michael\u2019s Hospital, Toronto.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"311"}}